The DOI matches its Crossref record; 349 of the 349 references it cites were found in a registry or an index.
Antimicrobial peptides: key components of the innate immune system
Open accessAbstract
Life-threatening infectious diseases are on their way to cause a worldwide crisis, as treating them effectively is becoming increasingly difficult due to the emergence of antibiotic resistant strains. Antimicrobial peptides (AMPs) form an ancient type of innate immunity found universally in all living organisms, providing a principal first-line of defense against the invading pathogens. The unique diverse function and architecture of AMPs has attracted considerable attention by scientists, both in terms of understanding the basic biology of the innate immune system, and as a tool in the design of molecular templates for new anti-infective drugs. AMPs are gene-encoded short (<100 amino acids), amphipathic molecules with hydrophobic and cationic amino acids arranged spatially, which exhibit broad spectrum antimicrobial activity. AMPs have been the subject of natural evolution, as have the microbes, for hundreds of millions of years. Despite this long history of co-evolution, AMPs have not lost their ability to kill or inhibit the microbes totally, nor have the microbes learnt to avoid the lethal punch of AMPs. AMPs therefore have potential to provide an important breakthrough and form the basis for a new class of antibiotics. In this review, we would like to give an overview of cationic antimicrobial peptides, origin, structure, functions, and mode of action of AMPs, which are highly expressed and found in humans, as well as a brief discussion about widely abundant, well characterized AMPs in mammals, in addition to pharmaceutical aspects and the additional functions of AMPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457 · cited 3×
“Enhanced understanding of this will be of great use in peptide-based drug designing (Zasloff, 1992; Zasloff, 2002; Hale and Hancock, 2007).”
BackgroundMethodAntimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Phylogenetic Perspectives in Innate Immunity
Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., & Ezekowitz, R. A. B. (1999) · Science · doi:10.1126/science.284.5418.1313 · Cited by 2,492
Zasloff, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5449 · Cited by 2,305
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Peters, T. (1985) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60065-0 · Cited by 2,181
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Sequence and specificity of two antibacterial proteins involved in insect immunity
Steiner, H., Hultmark, D., Engström, Å., Bennich, H., & Boman, H. G. (1981) · Nature · doi:10.1038/292246a0 · Cited by 1,427
Defensins. Natural peptide antibiotics of human neutrophils.
Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S., Daher, K., Bainton, D. F., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112120 · Cited by 1,416
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
Lai, Y., & Gallo, R. L. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.003 · Cited by 1,276
Amphipathic, α-helical antimicrobial peptides
Tossi, A., Sandri, L., & Giangaspero, A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<4::aid-bip30>3.0.co;2-m · Cited by 1,247
Mammalian defensins in the antimicrobial immune response
Selsted, M. E., & Ouellette, A. J. (2005) · Nature Immunology · doi:10.1038/ni1206 · Cited by 1,203
Antimicrobial peptides: premises and promises
Reddy, K. V. R., Yedery, R. D., & Aranha, C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.005 · Cited by 1,068
The co-evolution of host cationic antimicrobial peptides and microbial resistance
Peschel, A., & Sahl, H.-G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1441 · Cited by 1,062
Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria
Ayabe, T., Satchell, D. P., Wilson, C. L., Parks, W. C., Selsted, M. E., & Ouellette, A. J. (2000) · Nature Immunology · doi:10.1038/77783 · Cited by 1,060
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
LL-37, the only human member of the cathelicidin family of antimicrobial peptides
Dürr, U. H. N., Sudheendra, U. S., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.030 · Cited by 1,049
Matsuzaki, K. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00197-2 · Cited by 1,010
HULTMARK, D., STEINER, H., RASMUSON, T., & BOMAN, H. G. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb05991.x · Cited by 1,008
Defensins: Antimicrobial and Cytotoxic Peptides of Mammalian Cells
Lehrer, R. I., Lichtenstein, A. K., & Ganz, T. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.000541 · Cited by 991
Cathelicidins, multifunctional peptides of the innate immunity
Zanetti, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403147 · Cited by 988 · cited 11×
“Even in the presence of blood components, however, it can coordinate with other components of the innate immunity, such as recruiting neutrophils to the site of infection (Zanetti, 2004; Bowdish et al., 2005a).”
BackgroundInfluentialCationic peptides: effectors in innate immunity and novel antimicrobials
Hancock, R. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00092-5 · Cited by 978 · cited 2×
“Even though there is not much difference in lipid composition, Gram-negative bacteria differ from Gram-positive bacteria as the former have a smaller peptidoglycan layer and an outer membrane, in addition to a cytoplasmic membrane containing LPS, which acts as permeability barrier (Hancock, 2001).”
BackgroundThe relationship between peptide structure and antibacterial activity
Powers, J.-P. S., & Hancock, R. E. W. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.023 · Cited by 948
APD2: the updated antimicrobial peptide database and its application in peptide design.
Wang, G., Li, X., & Wang, Z. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn823 · Cited by 941
Park, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
Sørensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S., & Borregaard, N. (2001) · Blood · doi:10.1182/blood.v97.12.3951 · Cited by 894
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
Koczulla, R., von Degenfeld, G., Kupatt, C., Krötz, F., Zahler, S., Gloe, T., Issbrücker, K., Unterberger, P., Zaiou, M., Lebherz, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17545 · Cited by 863
APD: the Antimicrobial Peptide Database
Wang, Z. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh025 · Cited by 808
Frohm, M., Agerberth, B., Ahangari, G., Ståhle-Bäckdahl, M., Lidén, S., Wigzell, H., & Gudmundsson, G. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15258 · Cited by 803
Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils
Turner, J., Cho, Y., Dinh, N.-N., Waring, A. J., & Lehrer, R. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2206 · Cited by 798
Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1067 · Cited by 786
Lactoferrin: structure, function and applications
González-Chávez, S. A., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.07.020 · Cited by 759
Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jörnvall, H., Wigzell, H., & Gudmundsson, G. H. (2000) · Blood · doi:10.1182/blood.v96.9.3086 · Cited by 758
Dermcidin: A novel human antibiotic peptide secreted by sweat glands
Schittek, B., Hipfel, R., Sauer, B., Bauer, J., Kalbacher, H., Stevanovic, S., Schirle, M., Schroeder, K., Blin, N., Meier, F., et al. (2001) · Nature Immunology · doi:10.1038/ni732 · Cited by 730
Zanetti, M., Gennaro, R., & Romeo, D. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01050-o · Cited by 713
The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses
Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., & Hancock, R. E. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3883 · Cited by 713
Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations
Melo, M. N., Ferre, R., & Castanho, M. A. R. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2095 · Cited by 709
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
Antimicrobial peptides: The ancient arm of the human immune system
Wiesner, J., & Vilcinskas, A. (2010) · Virulence · doi:10.4161/viru.1.5.12983 · Cited by 684
Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37
Johansson, J., Gudmundsson, G. H., Rottenberg, M. E., Berndt, K. D., & Agerberth, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3718 · Cited by 661
Thomma, B., Cammue, B., & Thevissen, K. (2002) · Planta · doi:10.1007/s00425-002-0902-6 · Cited by 661
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
Mygind, P. H., Fischer, R. L., Schnorr, K. M., Hansen, M. T., Sönksen, C. P., Ludvigsen, S., Raventós, D., Buskov, S., Christensen, B., De Maria, L., et al. (2005) · Nature · doi:10.1038/nature04051 · Cited by 657
Oppenheim, F. G., Xu, T., McMillian, F. M., Levitz, S. M., Diamond, R. D., Offner, G. D., & Troxler, R. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68522-9 · Cited by 652
Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., & Miller, S. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81750-x · Cited by 649
Giangaspero, A., Sandri, L., & Tossi, A. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2001.02494.x · Cited by 636
Lipid domains in bacterial membranes and the action of antimicrobial agents
Epand, R. M., & Epand, R. F. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.023 · Cited by 624
Vuong, C., Voyich, J. M., Fischer, E. R., Braughton, K. R., Whitney, A. R., DeLeo, F. R., & Otto, M. (2004) · Cellular Microbiology · doi:10.1046/j.1462-5822.2004.00367.x · Cited by 623
Lantibiotics: Peptides of Diverse Structure and Function
Willey, J. M., & van der Donk, W. A. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.080706.093501 · Cited by 621
Converting a Peptide into a Drug: Strategies to Improve Stability and Bioavailability
Adessi, C., & Soto, C. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867024606731 · Cited by 614
Antimicrobial peptides: an overview of a promising class of therapeutics
Giuliani, A., Pirri, G., & Nicoletto, S. (2007) · Open Life Sciences · doi:10.2478/s11535-007-0010-5 · Cited by 606
De Novo Antimicrobial Peptides with Low Mammalian Cell Toxicity
Javadpour, M. M., Juban, M. M., Lo, W.-C. J., Bishop, S. M., Alberty, J. B., Cowell, S. M., Becker, C. L., & McLaughlin, M. L. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9509410 · Cited by 597
Utsugi, T., Schroit, A. J., Connor, J., Bucana, C. D., & Fidler, I. J. (1991) · PubMed · Cited by 594
Vuong, C., Kocianova, S., Voyich, J. M., Yao, Y., Fischer, E. R., DeLeo, F. R., & Otto, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411374200 · Cited by 592
Production of β-defensins by human airway epithelia
Singh, P. K., Jia, H. P., Wiles, K., Hesselberth, J., Liu, L., Conway, B.-A. D., Greenberg, E. P., Valore, E. V., Welsh, M. J., Ganz, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14961 · Cited by 579
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V, Zasloff, M., & Wilson, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2410 · Cited by 577
Role of membranes in the activities of antimicrobial cationic peptides
Hancock, R. (2002) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00480-3 · Cited by 574
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., & Wright, S. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1291-1297.1995 · Cited by 573
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572 · cited 6×
“A literature review identifies no more than 30 papers aiming to address this problem Yang et al., 2004b; Moon et al., 2006; Mehrnejad et al., 2008; Renye and Somkuti, 2008; Panavas et al., 2009; Bommarius et al., 2010; Cao et al., 2010; Li et al., 2010; Shen et al., 2010.”
BackgroundInfluentialHuman Antimicrobial Peptides: Defensins, Cathelicidins and Histatins
De Smet, K., & Contreras, R. (2005) · Biotechnology Letters · doi:10.1007/s10529-005-0936-5 · Cited by 560
Boman, H. G., Agerberth, B., & Boman, A. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2978-2984.1993 · Cited by 551
Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus -Derived Proteinases
Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wójcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M., Pohl, J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4673-4679.2004 · Cited by 551
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
Chertov, O., Michiel, D. F., Xu, L., Wang, J. M., Tani, K., Murphy, W. J., Longo, D. L., Taub, D. D., & Oppenheim, J. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.2935 · Cited by 548
Niyonsaba, F., Ushio, H., Nakano, N., Ng, W., Sayama, K., Hashimoto, K., Nagaoka, I., Okumura, K., & Ogawa, H. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700599 · Cited by 544
Cole, A. M., Weis, P., & Diamond, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.12008 · Cited by 541
Primary structures of three human neutrophil defensins.
Selsted, M. E., Harwig, S. S., Ganz, T., Schilling, J. W., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112121 · Cited by 534
Direct inactivation of viruses by human granulocyte defensins
Daher, K. A., Selsted, M. E., & Lehrer, R. I. (1986) · Journal of Virology · doi:10.1128/jvi.60.3.1068-1074.1986 · Cited by 533
Gifford, J. L., Hunter, H. N., & Vogel, H. J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5373-z · Cited by 528
Peptides: Chemistry and Biology
Sewald, N., & Jakubke, H. (2002) · Wiley eBooks · doi:10.1002/352760068x · Cited by 525
Kokryakov, V. N., Harwig, S. S. L., Panyutich, E. A., Shevchenko, A. A., Aleshina, G. M., Shamova, O. V., Korneva, H. A., & Lehrer, R. I. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80175-t · Cited by 518
Cationic amphiphilic peptides with cancer-selective toxicity
Schweizer, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.043 · Cited by 517
Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins
Dennis, M. S., Zhang, M., Meng, Y. G., Kadkhodayan, M., Kirchhofer, D., Combs, D., & Damico, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205854200 · Cited by 508
Kragol, G., Lovas, S., Varadi, G., Condie, B. A., Hoffmann, R., & Otvos, L. (2001) · Biochemistry · doi:10.1021/bi002656a · Cited by 491
Monocyte-chemotactic activity of defensins from human neutrophils.
Territo, M. C., Ganz, T., Selsted, M. E., & Lehrer, R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114394 · Cited by 489
Lactoferrin: Lactoferrin: an important host defence against microbial and viral attack
Valenti, P., & Antonini, G. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5372-0 · Cited by 488
Discovery of five conserved β-defensin gene clusters using a computational search strategy
Schutte, B. C., Mitros, J. P., Bartlett, J. A., Walters, J. D., Jia, H. P., Welsh, M. J., Casavant, T. L., & McCray, P. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042692699 · Cited by 488
Mechanism of antimicrobial action of indolicidin
Subbalakshmi, C. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00008-1 · Cited by 474
Molecular mechanism of antimicrobial peptides: The origin of cooperativity
Huang, H. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.001 · Cited by 471
How do bacteria resist human antimicrobial peptides?
Peschel, A. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02333-8 · Cited by 465
Mookherjee, N., & Hancock, R. E. W. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6475-6 · Cited by 462
CAMP: a useful resource for research on antimicrobial peptides.
Thomas, S., Karnik, S., Barai, R. S., Jayaraman, V. K., & Idicula-Thomas, S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1021 · Cited by 462 · cited 1×
“Since then, more than 1400 AMPs have been isolated from bacteria, insects and other invertebrates, amphibians, birds, fishes, mammals, and plants (Wang and Wang, 2004; Wang et al., 2009a; Thomas et al., 2010).”
BackgroundAntimicrobial peptides in animals and their role in host defences
Brogden, K. A., Ackermann, M., McCray, P. B., & Tack, B. F. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00180-8 · Cited by 458
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37
Schmidtchen, A., Frick, I., Andersson, E., Tapper, H., & Björck, L. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03146.x · Cited by 439
Self-citationWu, Z., Hoover, D. M., Yang, D., Boulègue, C., Santamaria, F., Oppenheim, J. J., Lubkowski, J., & Lu, W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533186100 · Cited by 439
Crystallization of Antimicrobial Pores in Membranes: Magainin and Protegrin
Yang, L., Weiss, T. M., Lehrer, R. I., & Huang, H. W. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76448-4 · Cited by 437
Optimization of the antimicrobial activity of magainin peptides by modification of charge
Dathe, M., Nikolenko, H., Meyer, J., Beyermann, M., & Bienert, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02648-5 · Cited by 432
RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human Skin
Harder, J., & Schröder, J.-M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207587200 · Cited by 425
Drug discovery beyond the ‘rule-of-five’
Zhang, M.-Q., & Wilkinson, B. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.005 · Cited by 418
Interaction of Cationic Antimicrobial Peptides with Model Membranes
Zhang, L., Rozek, A., & Hancock, R. E. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104925200 · Cited by 410
Dathe, M., Wieprecht, T., Nikolenko, H., Handel, L., Maloy, W. L., MacDonald, D. L., Beyermann, M., & Bienert, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00055-0 · Cited by 409
Gunn, J. S., Ryan, S. S., van Velkinburgh, J. C., Ernst, R. K., & Miller, S. I. (2000) · Infection and Immunity · doi:10.1128/.68.11.6139-6146.2000 · Cited by 398
Electrically gated ionic channels in lipid bilayers
Ehrenstein, G., & Lecar, H. (1977) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500000123 · Cited by 393
Why are antibiotic resistance genes so resistant to elimination?
Salyers, A. A., & Amábile-Cuevas, C. F. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2321 · Cited by 375
Impact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 374
Charlet, M., Chernysh, S., Philippe, H., Hetru, C., Hoffmann, J. A., & Bulet, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21808 · Cited by 371
Interaction between Heat Shock Proteins and Antimicrobial Peptides
Otvos, O, I., Rogers, M. E., Consolvo, P. J., Condie, B. A., Lovas, S., Bulet, P., & Blaszczyk-Thurin, M. (2000) · Biochemistry · doi:10.1021/bi0012843 · Cited by 370
Experimental evolution of resistance to an antimicrobial peptide
Perron, G. G., Zasloff, M., & Bell, G. (2006) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2005.3301 · Cited by 369
A Re-evaluation of the Role of Host Defence Peptides in Mammalian Immunity
Bowdish, D., Davidson, D., & Hancock, R. (2005) · Current Protein & Peptide Science · doi:10.2174/1389203053027494 · Cited by 368
Schneider, J. J., Unholzer, A., Schaller, M., Schäfer-Korting, M., & Korting, H. C. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0657-1 · Cited by 366
Innate immunity and the normal microflora
Boman, H. G. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917301.x · Cited by 360
Tokumaru, S., Sayama, K., Shirakata, Y., Komatsuzawa, H., Ouhara, K., Hanakawa, Y., Yahata, Y., Dai, X., Tohyama, M., Nagai, H., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4662 · Cited by 358
Antimicrobial Peptides: Properties and Applicability
Hof, W. V. T., Veerman, E. C. I., Helmerhorst, E. J., & Amerongen, A. V. N. (2001) · Biological Chemistry · doi:10.1515/bc.2001.072 · Cited by 354
Patrzykat, A., Friedrich, C. L., Zhang, L., Mendoza, V., & Hancock, R. E. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.605-614.2002 · Cited by 354
Sitaram, N., & Nagaraj, R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00199-6 · Cited by 353
Design of model amphipathic peptides having potent antimicrobial activities
Blondelle, S. E., & Houghten, R. A. (1992) · Biochemistry · doi:10.1021/bi00165a020 · Cited by 352
Cold-shock induced high-yield protein production in Escherichia coli
Qing, G., Ma, L.-C., Khorchid, A., Swapna, G. V. T., Mal, T. K., Takayama, M. M., Xia, B., Phadtare, S., Ke, H., Acton, T., et al. (2004) · Nature Biotechnology · doi:10.1038/nbt984 · Cited by 350
Antibiotic peptides as mediators of innate immunity
Zasloff, M. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90115-u · Cited by 346
Bacterial Membrane Lipids: Where Do We Stand?
Cronan, J. E. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090851 · Cited by 345
Jones, D. E., & Bevins, C. L. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81160-2 · Cited by 341
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid
Singh, P. K., Tack, B. F., McCray, P. B., & Welsh, M. J. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.5.l799 · Cited by 341
Ganz, T., & Lehrer, R. I. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90145-7 · Cited by 337
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S., & Phoenix, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630589 · Cited by 332
Takahashi, D., Shukla, S. K., Prakash, O., & Zhang, G. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.023 · Cited by 331
Membrane thinning caused by magainin 2
Ludtke, S., He, K., & Huang, H. (1995) · Biochemistry · doi:10.1021/bi00051a026 · Cited by 327
Cathelicidins: a family of endogenous antimicrobial peptides
Lehrer, R. I., & Ganz, T. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200201000-00004 · Cited by 324
Jones, A. L., Hulett, M. D., & Parish, C. R. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01320.x · Cited by 318
Immunomodulatory Activities of Small Host Defense Peptides
Bowdish, D. M. E., Davidson, D. J., Scott, M. G., & Hancock, R. E. W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1727-1732.2005 · Cited by 316
Antimicrobial Peptides: Current Status and Therapeutic Potential
Koczulla, A. R., & Bals, R. (2003) · Drugs · doi:10.2165/00003495-200363040-00005 · Cited by 306
Inducible Antibacterial Defence System in Drosophila
BOMAN, H. G., NILSSON, I., & RASMUSON, B. (1972) · Nature · doi:10.1038/237232a0 · Cited by 305
Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide
Bals, R., Weiner, D. J., Moscioni, A. D., Meegalla, R. L., & Wilson, J. M. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.6084-6089.1999 · Cited by 302
Cole, A. M., Hong, T., Boo, L. M., Nguyen, T., Zhao, C., Bristol, G., Zack, J. A., Waring, A. J., Yang, O. O., & Lehrer, R. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052706399 · Cited by 298
The antimicrobial peptide‐sensing system aps of Staphylococcus aureus
Li, M., Cha, D. J., Lai, Y., Villaruz, A. E., Sturdevant, D. E., & Otto, M. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05986.x · Cited by 297
Canny, G., Levy, O., Furuta, G. T., Narravula-Alipati, S., Sisson, R. B., Serhan, C. N., & Colgan, S. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052533799 · Cited by 295 · cited 1×
“To date, BPI has been isolated from rabbit PMN cells, human epithelial cells and PMN cells (Canny et al., 2002).”
BackgroundMechanisms of action of newer antibiotics for Gram-positive pathogens
Hancock, R. E. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70051-7 · Cited by 295
Basis for Selectivity of Cationic Antimicrobial Peptides for Bacterial Versus Mammalian Membranes
Glukhov, E., Stark, M., Burrows, L. L., & Deber, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507042200 · Cited by 294
Antimicrobial Peptide Resistance Mechanisms of Human Bacterial Pathogens
(2006) · Current Issues in Molecular Biology · doi:10.21775/cimb.008.011 · Cited by 289
Gram-positive three-component antimicrobial peptide-sensing system
Li, M., Lai, Y., Villaruz, A. E., Cha, D. J., Sturdevant, D. E., & Otto, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702159104 · Cited by 288
The roles of cathelicidin LL-37 in immune defences and novel clinical applications
Nijnik, A., & Hancock, R. E. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32831ac517 · Cited by 287
Cationic Antimicrobial Peptides and Their Multifunctional Role in the Immune System
Scott, M. G., & Hancock, R. E. W. (2000) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v20.i5.40 · Cited by 286
Changes in electric charge and phospholipids composition in human colorectal cancer cells
Dobrzyńska, I., Szachowicz-Petelska, B., Sulkowski, S., & Figaszewski, Z. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3557-3 · Cited by 285
Advances in antimicrobial peptide immunobiology
Yount, N. Y., Bayer, A. S., Xiong, Y. Q., & Yeaman, M. R. (2006) · Peptide Science · doi:10.1002/bip.20543 · Cited by 278
Corruption of Innate Immunity by Bacterial Proteases
Potempa, J., & Pike, R. N. (2009) · Journal of Innate Immunity · doi:10.1159/000181144 · Cited by 276
Gesell, J., Zasloff, M., & Opella, S. J. (1997) · Journal of Biomolecular NMR · doi:10.1023/a:1018698002314 · Cited by 274
Scott, M. G., Vreugdenhil, A. C. E., Buurman, W. A., Hancock, R. E. W., & Gold, M. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.549 · Cited by 270
Hazlett, L., & Wu, M. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1022-4 · Cited by 270
Immunomodulatory Properties of Defensins and Cathelicidins
Bowdish, D. M. E., Davidson, D. J., & Hancock, R. E. W. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-29916-5_2 · Cited by 269
Ganz, T., & Lehrer, R. I. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00076-f · Cited by 261
Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model
Torrent, M., Andreu, D., Nogués, V. M., & Boix, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016968 · Cited by 260
Nagaoka, I., Hirota, S., Niyonsaba, F., Hirata, M., Adachi, Y., Tamura, H., & Heumann, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3329 · Cited by 258 · cited 2×
“…of leukocyte (Welling et al., 1998), chemokine production (Territo et al., 1989; Chertov et al., 1996; Scott et al., 2002; Grutkoski et al., 2003), and anti-inflammatory properties (Turner et al., 1998; Scott and Hancock, 2000; Scott et al., 2000a; Scott et al., 2000b; Nagaoka et al., 2001).”
BackgroundThe Cathelicidins - Structure, Function and Evolution
Tomasinsig, L., & Zanetti, M. (2005) · Current Protein & Peptide Science · doi:10.2174/1389203053027520 · Cited by 254
Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure
Shaykhiev, R., Beißwenger, C., Kändler, K., Senske, J., Püchner, A., Damm, T., Behr, J., & Bals, R. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00286.2004 · Cited by 254
Skerlavaj, B., Gennaro, R., Bagella, L., Merluzzi, L., Risso, A., & Zanetti, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28375 · Cited by 252
Rivas-Santiago, B., Hernandez-Pando, R., Carranza, C., Juarez, E., Contreras, J. L., Aguilar-Leon, D., Torres, M., & Sada, E. (2008) · Infection and Immunity · doi:10.1128/iai.01218-07 · Cited by 250
Expression of β‐defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells
Duits, L. A., Ravensbergen, B., Rademaker, M., Hiemstra, P. S., & Nibbering, P. H. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01430.x · Cited by 249
Activation of the complement system generates antibacterial peptides
Nordahl, E. A., Rydengård, V., Nyberg, P., Nitsche, D. P., Mörgelin, M., Malmsten, M., Björck, L., & Schmidtchen, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406678101 · Cited by 247
Self-citationSnake Cathelicidin from Bungarus fasciatus Is a Potent Peptide Antibiotics
Wang, Y., Hong, J., Liu, X., Yang, H., Liu, R., Wu, J., Wang, A., Lin, D., & Lai, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003217 · Cited by 246
Xiao, Y., Cai, Y., Bommineni, Y. R., Fernando, S. C., Prakash, O., Gilliland, S. E., & Zhang, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507180200 · Cited by 242
Orivel, J., Redeker, V., Le Caer, J.-P., Krier, F., Revol-Junelles, A.-M., Longeon, A., Chaffotte, A., Dejean, A., & Rossier, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100216200 · Cited by 239
Cathelicidin LL-37: A Multitask Antimicrobial Peptide
Bucki, R., Leszczyńska, K., Namiot, A., & Sokołowski, W. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0057-2 · Cited by 235
Characterization of Novel Cysteine-rich Antimicrobial Peptides from Scorpion Blood
Ehret-Sabatier, L., Loew, D., Goyffon, M., Fehlbaum, P., Hoffmann, J. A., van Dorsselaer, A., & Bulet, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29537 · Cited by 229
Histatins: Antimicrobial peptides with therapeutic potential
Kavanagh, K., & Dowd, S. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022971 · Cited by 223 · cited 4×
“, 2008) thereby causing efflux of ATP, resulting in depletion of intracellular ATP contents and ultimately death (Tsai and Bobek, 1998; Rothstein et al., 2001; Kavanagh and Dowd, 2004).”
BackgroundInfluentialMalm, J., Sørensen, O., Persson, T., Frohm-Nilsson, M., Johansson, B., Bjartell, A., Lilja, H., Ståhle-Bäckdahl, M., Borregaard, N., & Egesten, A. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.4297-4302.2000 · Cited by 223
Ovchinnikova, T. V., Balandin, S. V., Aleshina, G. M., Tagaev, A. A., Leonova, Y. F., Krasnodembsky, E. D., Men’shenin, A. V., & Kokryakov, V. N. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.078 · Cited by 220
Mecke, A., Lee, D.-K., Ramamoorthy, A., Orr, B. G., & Banaszak Holl, M. M. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.062596 · Cited by 216
Klüver, E., Schulz-Maronde, S., Scheid, S., Meyer, B., Forssmann, W.-G., & Adermann, K. (2005) · Biochemistry · doi:10.1021/bi050272k · Cited by 215
Oudhoff, M. J., Bolscher, J. G. M., Nazmi, K., Kalay, H., van't Hof, W., Amerongen, A. V. N., & Veerman, E. C. I. (2008) · The FASEB Journal · doi:10.1096/fj.08-112003 · Cited by 215
The innate immune system in cystic fibrosis lung disease
Bals, R., Weiner, D. J., & Wilson, J. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6277 · Cited by 213
Liu, L., Zhao, C., Heng, H. H. Q., & Ganz, T. (1997) · Genomics · doi:10.1006/geno.1997.4801 · Cited by 213
Auvynet, C., & Rosenstein, Y. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07360.x · Cited by 212
Marshall, S. H., & Arenas, G. (2003) · Electronic Journal of Biotechnology · doi:10.2225/vol6-issue3-fulltext-1 · Cited by 212
Alamethicin and related peptaibols ? model ion channels
Sansom, M. S. P. (1993) · European Biophysics Journal · doi:10.1007/bf00196915 · Cited by 210
Antibacterial and Enzymic Basic Proteins from Leukocyte Lysosomes: Separation and Identification
Zeya, H. I., & Spitznagel, J. K. (1963) · Science · doi:10.1126/science.142.3595.1085 · Cited by 210
Lien, S., & Lowman, H. B. (2003) · Trends in Biotechnology · doi:10.1016/j.tibtech.2003.10.005 · Cited by 209
Structure-Based Design of an Indolicidin Peptide Analogue with Increased Protease Stability,
Rozek, A., Powers, J.-P. S., Friedrich, C. L., & Hancock, R. E. W. (2003) · Biochemistry · doi:10.1021/bi035643g · Cited by 206
Wu, Y., He, K., Ludtke, S. J., & Huang, H. W. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)80418-2 · Cited by 205
Chen, X., Niyonsaba, F., Ushio, H., Okuda, D., Nagaoka, I., Ikeda, S., Okumura, K., & Ogawa, H. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.03.014 · Cited by 203
Strömstedt, A. A., Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00477-08 · Cited by 200
Self-citationHagfish intestinal antimicrobial peptides are ancient cathelicidins
Uzzell, T., Stolzenberg, E. D., Shinnar, A. E., & Zasloff, M. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.024 · Cited by 198
Nizet, V. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.005 · Cited by 194
Penaeidins, a family of antimicrobial peptides from penaeid shrimp (Crustacea, Decapoda)
Destoumieux‐Garzón, D., Muñoz, M., Bulet, P., & Evelyne Bachère, B. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000764 · Cited by 193
Distribution of lipids in cytoplasmic and outer membranes of Escherichia coli K12
Lugtenberg, E. J. J., & Peters, R. (1976) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(76)90279-4 · Cited by 189
Anticandida Activity Is Retained in P-113, a 12-Amino-Acid Fragment of Histatin 5
Rothstein, D. M., Spacciapoli, P., Tran, L. T., Xu, T., Roberts, F. D., Dalla Serra, M., Buxton, D. K., Oppenheim, F. G., & Friden, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1367-1373.2001 · Cited by 188
Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide
Lee, H. S., Park, C. B., Kim, J. M., Jang, S. A., Park, I. Y., Kim, M. S., Cho, J. H., & Kim, S. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.041 · Cited by 188
Antimicrobial activities of heparin‐binding peptides
Andersson, E., Rydengård, V., Sonesson, A., Mörgelin, M., Björck, L., & Schmidtchen, A. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04035.x · Cited by 187
Self-citationSaito, T., Kawabata, S.-I., Shigenaga, T., Takayenoki, Y., Cho, J., Nakajima, H., Hirata, M., & Iwanaga, S. (1995) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124818 · Cited by 186
Dathe, M., Nikolenko, H., Klose, J., & Bienert, M. (2004) · Biochemistry · doi:10.1021/bi035948v · Cited by 186
The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides
Dorschner, R. A., Lopez‐Garcia, B., Peschel, A., Kraus, D., Morikawa, K., Nizet, V., & Gallo, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4406com · Cited by 186
Anti-microbial properties of histone H2A from skin secretions of rainbow trout, Oncorhynchus mykiss
FERNANDES, J. M. O., KEMP, G. D., MOLLE, M. G., & SMITH, V. J. (2002) · Biochemical Journal · doi:10.1042/bj20020980 · Cited by 184
Lai, Y., Villaruz, A. E., Li, M., Cha, D. J., Sturdevant, D. E., & Otto, M. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05540.x · Cited by 183
Bacterial Evasion of Antimicrobial Peptides by Biofilm Formation
Otto, M. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-29916-5_10 · Cited by 182
Human Salivary Histatins: Promising Anti-Fungal Therapeutic Agents
Tsai, H., & Bobek, L. A. (1998) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411980090040601 · Cited by 182
Bals, R., Goldman, M. J., & Wilson, J. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.3.1225-1232.1998 · Cited by 179
Cationic antimicrobial peptides: towards clinical applications
Hancock, R. E. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.8.1723 · Cited by 176
Colman, R. W., Jameson, B. A., Lin, Y., Johnson, D., & Mousa, S. A. (2000) · Blood · doi:10.1182/blood.v95.2.543 · Cited by 171
Proteolysis of Human Thrombin Generates Novel Host Defense Peptides
Papareddy, P., Rydengård, V., Pasupuleti, M., Walse, B., Mörgelin, M., Chalupka, A., Malmsten, M., & Schmidtchen, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000857 · Cited by 168
Self-citationPokorny, A., & Almeida, P. F. F. (2004) · Biochemistry · doi:10.1021/bi0497087 · Cited by 167
Chen, J., Falla, T. J., Liu, H., Hurst, M. A., Fujii, C. A., Mosca, D. A., Embree, J. R., Loury, D. J., Radel, P. A., Cheng Chang, C., et al. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<88::aid-bip80>3.0.co;2-k · Cited by 166
Brumfitt, W. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf190 · Cited by 166
Processing of Seminal Plasma hCAP-18 to ALL-38 by Gastricsin
Sørensen, O. E., Gram, L., Johnsen, A. H., Andersson, E., Bangsbøll, S., Tjabringa, G. S., Hiemstra, P. S., Malm, J., Egesten, A., & Borregaard, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301608200 · Cited by 164
Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis
Chan, K. S., Carbajal, S., Kiguchi, K., Clifford, J., Sano, S., & DiGiovanni, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3197 · Cited by 164
Antimicrobial peptides in toroidal and cylindrical pores
Mihajlovic, M., & Lazaridis, T. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.04.004 · Cited by 163
Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions
Kacprzyk, L., Rydengård, V., Mörgelin, M., Davoudi, M., Pasupuleti, M., Malmsten, M., & Schmidtchen, A. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.06.020 · Cited by 163
Self-citationPanavas, T., Sanders, C., & Butt, T. R. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-566-4_20 · Cited by 163
Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics.
Guichard, G., Benkirane, N., Zeder-Lutz, G., van Regenmortel, M. H., Briand, J. P., & Muller, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9765 · Cited by 162
Cited by
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Antimicrobial peptides: mechanism of action, activity and clinical potential
Zhang, Q.-Y., Yan, Z.-B., Meng, Y.-M., Hong, X.-Y., Shao, G., Ma, J.-J., Cheng, X.-R., Liu, J., Kang, J., & Fu, C.-Y. (2021) · Military Medical Research · doi:10.1186/s40779-021-00343-2 · Cited by 1,065
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Antimicrobial peptides as therapeutic agents: opportunities and challenges
Mahlapuu, M., Björn, C., & Ekblom, J. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1796576 · Cited by 484
Metadata
- Authors
- Pasupuleti, M., Schmidtchen, A., & Malmsten, M.
- Venue
- Critical Reviews in Biotechnology
- Publisher
- Informa UK Limited
- Published
- 2011-11-11
- Volume
- 32
- Issue
- 2
- Pages
- 143-171
- ISSN
- 0738-8551 (ISSN-L)
- 1549-7801
- OpenAlex
- W2013133956
- Cited by
- 799
- References
- 349
- FWCI
- 21.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.